CompletedNot Applicable

n3 PUFA and Muscle-disuse Atrophy in Young Women

Canada20 participantsStarted 2017-02-28

Plain-language summary

This study will examine the influence of n3 PUFA supplementation on the rate of muscle atrophy in women undergoing 2 weeks of unilateral limb immobilization. Assessments in skeletal muscle strength and skeletal muscle volume will also me made before, after and in recovery from immobilization.

Who can participate

Age range18 Years – 30 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female * Aged 18-30 years Exclusion Criteria: * Take any analgesic or anti-inflammatory drugs(s), prescription or non-prescription, chronically will be excluded * A history of neuromuscular problems or muscle and/or bone wasting diseases * Any acute or chronic illness, cardiac, pulmonary, liver, or kidney abnormalities, uncontrolled hypertension, insulin- or non-insulin dependent diabetes or other metabolic disorders-all ascertained through medical history screening questionnaires * Use medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescription strength acne medications) * Fish allergy

What they're measuring

Muscle Volume

Timeframe: Baseline (0 days), After (14 days) of unilateral limb immobilization and at 14 days post immobilization

Trial details

NCT IDNCT03059836

SponsorMcMaster University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-02-28

View on ClinicalTrials.gov More Muscle Atrophy trials